Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 9/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MPI | P34949 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31756884 | 1.00 | GPR84 (0.54) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL24882293 | 0.89 | GPR84 (0.58) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL24882476 | 0.89 | GPR84 (0.58) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL24882504 | 0.89 | GPR84 (0.58) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL28008785 | 0.89 | MEN1 (0.49) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL30022214 | 0.87 | MEN1 (0.49) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL17442110 | 0.87 | MEN1 (0.49) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL20987825 | 0.86 | GPR84 (0.46) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL20987827 | 0.86 | GPR84 (0.49) | GPR84MEN1KMT2AKDM4EALOX5 | |
| SCHEMBL1408488 | 0.83 | GPR84 (0.51) | GPR84MEN1KMT2AKDM4EALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109477993-B | Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods of use thereof | J大卫格莱斯顿研究机构 | 2023-03-28 | — | — | CN | disclosed |
| CN-114292190-A | Medium chain fatty acid esters of butylene glycol, compositions, oral formulations and methods of use thereof | J大卫格莱斯顿研究机构 | 2022-04-08 | — | — | CN | disclosed |
| CN-114269340-A | KCNT1 inhibitors and methods of use | 普拉克西斯精密药物股份有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-114206900-A | Neuroactive steroids and compositions thereof | 萨奇治疗股份有限公司 | 2022-03-18 | — | — | CN | disclosed |
| CN-111511860-A | Method for producing glass unit, pressure-sensitive adhesive sheet, and use of corrosion inhibitor | 日东电工株式会社 | 2020-08-07 | — | — | CN | disclosed |
| CN-102249831-B | New method for synthesizing 1,2,3-triaryl naphthalene derivatives | UNIV BEIJING CHEMICAL | 2015-04-08 | — | — | CN | disclosed |
| CN-102249831-A | New method for synthesizing 1,2,3-triaryl naphthalene derivatives | UNIV BEIJING CHEMICAL | 2011-11-23 | — | — | CN | disclosed |
| CN-102127458-A | Binary synergistic photosensitive liquid crystal orientation agent for disc liquid crystal orientation and preparation method | UNIV BEIJING SCIENCE & TECH | 2011-07-20 | — | — | CN | disclosed |
| WO-2008080832-A2 | CARBONITRIDES AS CATALYSTS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2008-07-10 | — | — | WO | disclosed |
| EP-1941946-A1 | Carbonitrides as catalysts | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2008-07-09 | — | — | EP | disclosed |
| CN-1678321-A | Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds | RIGEL PHARMACEUTICALS INC (US) | 2005-10-05 | — | — | CN | disclosed |
| US-6350875-B1 | COMPOUNDS FOR ELECTRONICS | THE UNIVERSITY OF SOUTHERN CALIFORNIA | 2002-02-26 | — | — | US | disclosed |
| US-20020016474-A1 | Synthesis of cyclooctatetraene derivatives and their use as electron transporters in organic light emitting diodes | WEBER WILLIAM P (US) | 2002-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016474-A1 | Synthesis of cyclooctatetraene derivatives and their use as electron transporters in organic light emitting diodes | SLC18A3, SLC18A2, SLC25A21 | GPR84 2088/4885MEN1 4818/4885KMT2A 3883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.